Ethiopia vs Latin America & Caribbean: Tuberculosis treatment success rate
Tuberculosis treatment success rate over time
- Ethiopia
- Latin America & Caribbean
How they compare
Ethiopia currently reports 96.0% against 71.0% in Latin America & Caribbean, a difference of 25.0%.
That makes Ethiopia's figure about 1.4 times Latin America & Caribbean's.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Ethiopia ahead.
Ethiopia ranks 15th and Latin America & Caribbean ranks 17th of 203 countries.
Ethiopia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ethiopia | Latin America & Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.8% | 75.0% | 3.8% | Ethiopia |
| 2010s | 88.3% | 74.8% | 13.5% | Ethiopia |
| 2020s | 88.8% | 71.5% | 17.2% | Ethiopia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Ethiopia or Latin America & Caribbean?
- Ethiopia, at 96.0% against 71.0% in Latin America & Caribbean as of 2023.
- What is the difference in tuberculosis treatment success rate between Ethiopia and Latin America & Caribbean?
- 25.0%, with Ethiopia ahead.
- How many years of comparable data are there for Ethiopia and Latin America & Caribbean?
- 24 years are reported by both, from 2000 to 2023.
- How do Ethiopia and Latin America & Caribbean rank globally for tuberculosis treatment success rate?
- Ethiopia ranks 15th and Latin America & Caribbean ranks 17th of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).